Skip to ContentSkip to Navigation
About us Latest news News News articles

Functional development at school age of newborn infants at risk

07 December 2011

PhD ceremony: Ms. E. Roze, 12.45 uur, Aula Academiegebouw, Broerstraat 5, Groningen

Dissertation: Functional development at school age of newborn infants at risk

Promotor(s): prof. A.F. Bos

Faculty: Medical Sciences

This thesis deals with the functional development at school age of newborn infants with perinatal risk factors for adverse outcome. We showed for the first time that the transplacental transfer of brominated flame retardants is associated with the motor, cognitive, and behavioral outcome of healthy newborn infants. Because of the widespread use of these compounds we concluded that these results are a cause of serious concern. In addition we found that in preterm children with periventricular hemorrhagic infarction, the majority had cerebral palsy with limited functional impairment at school age. We concluded that the functional outcome at school age of preterm children with this brain lesion was better than previously thought. In contrast, in infants with systemic disease in the neonatal period such as necrotizing enterocolitis and late-onset sepsis, we found that the outcome at school age was worse than one would expect. Their intelligence, for example, was barely better compared to preterm children with severe brain lesions. The pathophysiological mechanisms responsible for the functional impairments that we found at school age are complex and multifactorial. In preterm born infants white matter damage to the brain as a result of neuroinflammation plays a prominent role. We recommend to include measures of motor, intellectual, neuropsychological and behavioral functioning in a follow-up program. Adequate follow-up of newborn infants could lead to the early identification of functional impairments so as to identify opportunities for early intervention.

Last modified:13 March 2020 01.12 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.